Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line

Cancer Research

Volumn 56, Issue 24, 1996, Pages 5594-5599

  McConkey, David J ^a,b   Greene, Graham ^a   Pettaway, Curtis A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; DOXORUBICIN; INTERLEUKIN 1BETA CONVERTING ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ONCOPROTEIN; PROTEIN BCL 2; THAPSIGARGIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RESISTANCE; CARCINOMA CELL; CONTROLLED STUDY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CARCINOGENS; DOXORUBICIN; DRUG RESISTANCE; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; THAPSIGARGIN; TUMOR CELLS, CULTURED;

EID: 0029776580     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wingo, P. A., Tong, T , and Bolden, S Cancer Statistics, 1995 CA Cancer J Clin., 45: 8-30, 1995.
2. Catalona, W J., Smith, D. S., Ratliff, T L., and Basler, J. W. Detection of organ confined prostate cancer is increased through prostate-specific antigen based screening. JAMA. 270 948-954, 1993
3. Catalona, W. J , Richie, J P., Ahmann, F. R , Hudson, M. A , Scardino, P. T., Flanigan, R. C., deKemion, J. B., Ratliff, T. L , Kavoussi, L., Dalkin, B L., Waters, W. B., MacFarlane, M. T., and Southwick, P. C. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men J. Urol , 151: 1283-1290, 1995.
4. Eisenberger, M A Chemotherapy and palliation in prostate cancer In: D. A. S. Crawford (ed.), Cancer of the Prostate, pp. 369-396. New York: Marcel Dekker, 1993
5. Roehrborn, C. G Oncogenes and growth factors in prostatic carcinoma. In: P. M. M J. Berns, J. C. Romijn, and F. H. Schroder (eds), Mechanisms of Progression to Hormone-independent Growth of Breast and Prostatic Cancer, pp 97-122. Park Ridge, NJ: Parthenon Publishing Group, 1991.
6. Kreis, W, Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer. Cancer Invest., 13 296-312, 1995.
7. Thompson, C B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
8. Kerr, J F. R , Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer, 26: 239-257, 1972.
9. Raff, M. C Social controls on cell survival and cell death. Nature (Lond.), 356 397-400, 1992.
10. Weil, M., Jacobson, M. D., Coles, H. S. R., Davies, T J., Gardner, R. L., Raff, K. D., and Raff, M. C Constitutive expression of the machinery for programmed cell death. J. Cell Biol , 133, 1053-1059, 1996.
11. Hengartner, M. O., and Horvitz, H. R. Programmed cell death in Caenorhabditis elegans Curr. Opin Genet Dev., 4: 581-586, 1994.
12. Oltvai, Z. N., and Korsmeyer, S. J Checkpoints of dueling dimers foil death wishes. Cell. 79: 189-192, 1994.
13. Kerr, J F. R , and Searle, J Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch. Abt. B. Zellpathol , 13: 87-102, 1973.
14. Sandford, N L , Searle, J. W , and Kerr, J. F. R. Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation. Pathology, 16: 406-410, 1984.
15. Kyprianou, N., and Isaacs, J T. Activation of programmed cell death in the rat ventral prostate after castration Endocrinology, 122: 552-562, 1988
16. Buttyan, R , Olsson, C A , Pintar, J., Chang, C., Bandyk, M , Ng, P Y , and Sawczuk, I S. Induction of TRPM-2 gene in cells undergoing programmed cell death. Mol. Cell. Biol. 9 3473-3481, 1989.
17. 2+ -dependent endonuclease as an early event in castration-induced prostatic cell death Prostate, 13: 103-117, 1988
18. English, H F., Kypnanou, N., and Isaacs, J T. Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate. 15: 233-250, 1989.
19. Martikamen, P., and Isaacs, J Role of calcium in the programmed death of rat prostatic glandular cells. Prostate, 17, 175-187, 1990.
20. Kyprianou, N., English, H. F, and Isaacs, J T Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res , 50: 3748-3753, 1990
21. Brandstrom, A, Westin, P., Bergh, A., Cajander, S., and Damber, J E. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat Cancer Res., 54 3594-3601, 1994.
22. Berchem, G J., Bosseler, M., Sugars, L. Y , Voeller, H. J , Zeitlin, S., and Gelmann, E. P. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells Cancer Res., 55: 735-738, 1995.
23. Raffo, A J , Perlman, H., Chen, M. W , Day, M. L., Streitman, J S , and Buttyan, R Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in viva. Cancer Res., 55: 4438-4445, 1995.
24. McDonnell, T. J , Troncoso, P , Bnsbay, S M., Logothetis, C , Chung, L. W. K., Hsieh, J. T , Tu, S. M , and Campbell, M. L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940-6944, 1992
25. Colombel, M., Symmans, F., Gil, S., O'Toole, K. M., Chopin, D., Benson, M , Olsson, C. A., Korsmeyer, S., and Buttyan, R Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol., 143: 390-400, 1993
26. Furuya, Y , Krajewski, S., Epstein, J. I., Reed, J. C., and Isaacs, J. Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clin Cancer Res., 2: 389-398, 1996
27. Krajewska, M , Krajewski, S., Epstein, J I., Shabaik, A., Sauvageot, J., Song, K., Kitada, S., and Reed, J. C Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers Am J Pathol. 148 1567-1576, 1996
28. Bubendorf, L , Sauter, G , Moch, H., Jordan, P., Blochlinger, A., Gasser, T C., and Mihatsch, M. J Prognostic significance of BCL-2 in clinically localized prostate cancer Am J. Pathol. 148, 1557-1565, 1996
29. Veldscholte, J., Ris-Stalpers, C., Kuiper, G G. Jenster, G , Berrevoets, C., Claassen, E , Rooij, H. C v , Trapman, J , Brinkman, A O , and Mulder, E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys. Res. Commun, 173, 534-540, 1990.
30. Pettaway, C. A., Pathak, S , Greene, G., Ramirez, E., Wilson, M R., Killion, J. J , and Fidler, I. J Selection of highly metastatic variants of different human prostatic carcinomas utilizing orthotopic implantation in nude mice Clin. Cancer Res, 2: 1627-1636, 1996
31. Dong, Z., Ward, N E., Fan, D., Gupta, K P , and O'Brian, C. A. In vitro model for intrinsic drug resistance effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells Mol. Pharmacol., 39: 563-569, 1991.
32. 2+ concentration. Arch. Biochem Biophys , 269: 365-370, 1989.
33. Burton, K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J , 62 315-323, 1956.
34. Fernandez, A., Fosdick, L. J., Marin, M C., Diaz, C., McDonnell, T. J , Ananthaswamy, H N., and McConkey, D. J. Differential regulation of endogenous endonuclease activation in isolated murine fibroblast nuclei by ras and bcl-2 Oncogene, 10: 769-774, 1995.
35. 2+. Oncogene, 12: 2259-2266, 1996
36. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet, 1: 571-573, 1889.
37. Fidler, I. J. Critical factors in the biology of human cancer metastasis. Cancer Res., 50: 6130-6138, 1990.
38. Stephenson, R. A , Dinney, C. P N , Gohji, K., Ordonez, N. G., Killton, J. J., and Fidler, I. J. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. Natl Cancer Inst., 84: 951-957, 1992.